Abstract
Four adult marmosets were treated with increasing doses of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'-methyl-MPTP) in the range 0.23-4.3 mg/kg i.p. to give a cumulative dose of 11.0-11.6 mg/kg over a 6-10 day period. After 4 days of treatment, and as the dosage was gradually increased, the animals exhibited mild motor deficits. These abnormalities slowly declined over the following 1-6 week period. In contrast, similar treatment of common marmosets with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) (1-4 mg/kg i.p.) for 3-5 days in a cumulative dose of 6.9-9.2 mg/kg produced gross impairment of motor function which persisted throughout the 5 weeks period of observation. Administration of 2'-methyl-MPTP for 6-10 days caused some decrease in dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC), but not homovanillic acid (HVA) content in the caudate nucleus in animals 5-6 weeks after the start of treatment. There was a small decrease in [3H]dopamine uptake into putamen synaptosomes. This contrasted with the marked decreases in all these parameters observed after MPTP treatment of common marmosets. Histological examination of the substantia nigra from the four animals treated with 2'-methyl-MPTP did not show de...Continue Reading
References
Dec 1, 1979·Psychiatry Research·G C DavisI J Kopin
Nov 1, 1989·Neuropharmacology·S RoseC D Marsden
May 3, 1987·Nature·R J D'AmatoS H Snyder
Feb 9, 1988·European Journal of Pharmacology·M V KindtR E Heikkila
Aug 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·R E HeikkilaT P Singer
Mar 18, 1986·European Journal of Pharmacology·S K YoungsterR E Heikkila
Apr 29, 1987·Biochemical and Biophysical Research Communications·J N ChaconT G Truscott
Jan 21, 1985·Life Sciences·J N JohannessenS P Markey
Oct 8, 1985·European Journal of Pharmacology·E MelamedA Uzzan
Jan 21, 1985·Life Sciences·R E HeikkilaR C Duvoisin
Jul 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·R S BurnsI J Kopin
Apr 30, 1984·Biochemical and Biophysical Research Communications·K ChibaN Castagnoli
Sep 7, 1984·Neuroscience Letters·P JennerC D Marsden
Oct 30, 1984·European Journal of Pharmacology·G CohenM D Yahr
Jun 29, 1984·Science·R E HeikkilaR C Duvoisin
Jun 1, 1984·Neuropharmacology·R E HeikkilaR C Duvoisin
May 1, 1982·Neuropharmacology·C J Carter
Citations
Jan 1, 1996·Journal of Neural Transmission·M Gerlach, P Riederer
Dec 12, 1991·European Journal of Pharmacology·M GerlachM B Youdim
Mar 1, 1997·Neurobiology of Aging·I IrwinJ W Langston